Greenwood Genetics Center Transitions to Affymetrix's CytoScan Dx Citing Benefits to Clinicians, Labs | GenomeWeb

NEW YORK (GenomeWeb) – When Greenwood Genetics Center announced last week that it is now offering Affymetrix's US Food and Drug Administration-cleared CytoScan Dx Assay to its clinicians for chromosomal microarray analysis, it became the first laboratory in the US to do so.

Though the Greenwood, SC-based center already offers a laboratory-developed test based on Affymetrix's research use only CytoScan HD product, the addition of the CytoScan Dx Assay appeals to users for multiple reasons, according to Alka Chaubey, director of the center's cytogenetics laboratory.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.